C-CAMP-BIRAC post National Bio Entrepreneurship Competition 2018; revolutionary ideas sought by September 16th

2018-08-31 06:00:24

In its second edition, The National Bio Entrepreneurship Competition (NBEC) 2018 is inviting path-breaking revolutionary and scalable business ideas in the life sciences domain by September 16th, 2018By Team ABLEThe National Bio Entrepreneurship Competition is a national platform to attract, identify, and nurture bio-entrepreneurs with path-breaking, novel and scalable business ideas with signific

Read more

DBT inks MoU with IEA on enhancing innovation for the clean energy transition

2018-08-31 05:57:52

The MoU aims to deepen co-operation in support of clean energy innovations to accelerate RD&D of clean energy technologies in India.By Team ABLEThe Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India, and the International Energy Agency (IEA) signed a Memorandum of Understanding (MoU) on Enhancing Innovation for the Clean Energy Transition. The MoU w

Read more

AIIMS, IIT Delhi to develop low cost med-tech solutions

2018-08-30 06:39:33

The program targets to come out with technology driven low cost medical solutions along with developing new items and equipment, which can be used for conducting diagnosis and other medical tests.By Team ABLEThe All India Institute of Medical Science (AIIMS) and Indian Institute of Technology-Delhi (IIT-D) have collaborated on exchanging research proposals to develop technology driven health care

Read more

US-Mexico reach preliminary NAFTA deal; agriculture biotechnology given top priority

2018-08-30 06:38:48

The modernized agreement will include 21st century agriculture biotechnology not addressed in the original NAFTA or Trans-Pacific Partnership.By Team ABLEAfter a year of ongoing negotiations, the United States and Mexico reached a preliminary agreement on a revamped North American Free Trade Agreement on Monday, Aug. 27. If Canada can reach a similar agreement, a finalized updated NAFTA may be wit

Read more

EU, India forge ties on influenza vaccine development

2018-08-30 06:37:41

EU and the Department of Biotechnology (DBT), government of India, have committed approximately Rs 120 crore each to fund this joint call.By Team ABLEThe European Union (EU) and India, on August 30, 2018, have entered into a collaboration in research and innovation to develop a next-generation influenza vaccine to protect citizens worldwide.An official from the Office of EU in India had said that,

Read more

Laurus Labs gets USFDA nod for diabetes drug

2018-08-30 06:36:08

The company has received approval from United States Food and Drug Administration (USFDA) for Bristol-Myers Squibb’s diabetes drug equivalent Metformin hydrochloride tablets.By Team ABLELaurus Labs has announced that the company has received approval from the US health regulator for its Metformin hydrochloride tablets used for treatment of diabetes.The company has received approval from United S

Read more

FDA launches Complex Innovative Designs Pilot Program to ease clinical trial simulations

2018-08-30 06:34:52

CID refers to complex adaptive, Bayesian, and other novel designs, with a focus on designs for which simulations are necessary to evaluate the clinical trial properties (e.g. power, type I error probability, etc).By Team ABLEThe US FDA on Monday August 28, 2018, has launched a pilot meeting program for complex innovative designs (CID) in a Federal Register notice titled, “Complex Innovative Desi

Read more

UN to hold High-Level Meeting on tuberculosis on September 26th; PLOS special issue calls for research papers

2018-08-29 07:27:24

This is United Nations General Assembly’s first-ever high-level meeting on tuberculosis (TB) to accelerate efforts in ending TB. The theme of the meeting is “United to end tuberculosis: an urgent global response to a global epidemic”.By Team ABLEThe Heads of State will gather in New York on 26 September, 2018, at the United Nations General Assembly first-ever high-level meeting on tuberculos

Read more

TB Alliance initiates SimpliciTB clinical trial

2018-08-29 07:25:33

This new pivotal trial examines potential of BPaMZ regimen to shorten treatment for tuberculosis and multi drug-resistant tuberculosis.By Team ABLETB Alliance has initiated a pivotal clinical trial, SimpliciTB (pronounced: sim-plis-i-tee-bee), that will evaluate whether a new four-drug regimen can treat most types of tuberculosis (TB) including multidrug-resistant TB (MDR-TB) more quickly and effe

Read more

San Diego researchers to test novel drug combination against toughest breast cancers

2018-08-28 08:32:21

Researchers at University of California San Diego School of Medicine have launched a phase Ib clinical trial to assess the safety and tolerability of cirmtuzumab, in combination with standard chemotherapy, to treat metastatic or locally advanced breast cancer that cannot be surgically removed.By Team ABLEResearchers at University of California San Diego School of Medicine have launched a phase Ib

Read more